
Use Policies
Articles
-
Jul 11, 2024 |
atsjournals.org | Byron C. Jaeger |Use Policies |Surya P. Bhatt |Chaoqi Wu
Supplements PDF
-
Jul 9, 2024 |
atsjournals.org | Use Policies |Yueh-Ying Han |Wei Chen |Erick Forno
Supplements PDF
-
Jun 25, 2024 |
atsjournals.org | Use Policies |Elizabeth Gay |Olaf L. Cremer |Brian Bartek
Supplements PDF
-
Jun 21, 2024 |
atsjournals.org | Use Policies |Jonathan Feldman |Deepa Rastogi |Karen Warman
Supplements PDF
-
Mar 15, 2024 |
atsjournals.org | Use Policies |Naoya Tanabe
Chronic obstructive pulmonary disease (COPD) is an increasingly common global burden (1). The diagnosis of COPD is currently made on the basis of the presence of airflow limitation, defined as an FEV1/FVC ratio <0.7 on spirometry. However, airflow limitation on spirometry is detectable only at the late stage of cumulative damage to airways and lung parenchyma.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →